Immunogenetic Determinants of Metastatic Cells

  • S. Katzav
  • P. De Baetselier
  • B. Tartakovsky
  • E. Gorelik
  • S. Segal
  • M. Feldman
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)


The progression of metastases is controlled by a series of cellular interactions between host and tumor cells. The generation of blood-bourne metastases is initiated by tumor cells capable of adhering to capillary basement membranes, followed by penetration, apparently via enzymatic degradation, of its proteins (1–3).


Metastatic Cell Tumor Cell Population Spontaneous Metastasis Capillary Basement Membrane Parental Haplotype 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Klebe, H.K., Isolation of a collagen-dependent cell attachment factor. Nature 250: 248 (1974).CrossRefGoogle Scholar
  2. 2.
    Liotta, L.A., K. Tryggvason, S. Garbisa, I. Hart, C.M. Foltz and S. Shafie, Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67 (1980)CrossRefGoogle Scholar
  3. 3.
    Murry, J.C., S. Garbisa and L. Liotta, The role of tumor cell basement interactions in the metastatic process. In: “Metastasis,” p. 169, editors: Hellman, K., P. Hilgard and S. Eccles, Martinus Nijhoff, Publishers, The Hague, 1980.CrossRefGoogle Scholar
  4. 4.
    Gorelik, E., M. Fogel, M. Feldman and S. Segal, Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. J. Nat. Cancer Inst. 63: 1397 (1979).Google Scholar
  5. 5.
    Gorelik, E., M. Feldman and S. Segal, Selection of 3LL concomitantly selected for increased metastatic potency. Cancer Immunol. Immunother., in press.Google Scholar
  6. 6.
    Fidler, I.J. and G.L. Nicolson, Organ selectivity for implantation, survival and growth of B16 melanoma variant tumor lines. J. Natl. Cancer Inst. 57: 1199 (1976).Google Scholar
  7. 7.
    Brunson, K.W., G. Beattie and G.L. Nicolson, Selection and altered tumour cell properties of brain colonizing metastatic melanoma. Nature 272: 543.Google Scholar
  8. 8.
    Folkman, J. and C. Handeschild, C., Angiogenesis in vitro. Nature 288: 551 (1981)CrossRefGoogle Scholar
  9. 9.
    Fogel, M., E. Gorelik, S. Segal and M. Feldman, Differences in cell surface antigens of tumor metastases and those of the local tumor. J. Natl. Cancer Inst. 62: 585 (1979)Google Scholar
  10. 10.
    Gorelik, E., M. Fogel, S. Segal and M. Feldman, Tumor associated antigenic differences between the primary and the descendant metastatic tumor cell population. J. Supramol. Struc. 12: 385 (1980).CrossRefGoogle Scholar
  11. 11.
    Haywood, G.R. and C.F. McKhann, Antigenic specificities on murine sarcoma cells: Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity. J. Exp. Med. 133: 1171 (1971).CrossRefGoogle Scholar
  12. 12.
    Brodt, P. and J. Gordon, Anti-tumor immunity in B lymphocyte deprived mice. I. Immunity to chemically induced tumor. J. Immunol. 121: 359 (1978).Google Scholar
  13. 13.
    DeBaetselier, P., S. Katzav, E. Gorelik, M. Feldman and S. Segal, Differential expression of H-2 gene products in tumor cells is associated with their metastatogenic proper¬ties. Nature 288: 179 (1980).CrossRefGoogle Scholar
  14. 14.
    Katzav, S., P. DeBaetselier, E. Gorelik, M. Feldman and S. Segal, Immunogenetic control of metastasis formation by a methylcholanthrene-induced tumor (T10) in mice. Transpl. Proc. 13: 742 (1981).Google Scholar
  15. 15.
    Fidler, I.J. and M.L. Kripke, Metastatis results from preexisting variant cells within a malignant tumor. Science 197: 893 (1977).CrossRefGoogle Scholar
  16. 16.
    Kripke, M.L., E. Gruys and I.J. Fidler, Metastatic heterogeneity of cells from an ultraviolet light induced murine fibrosarcoma of recent origin. Cancer Research 38: 2962 (1978).Google Scholar
  17. 17.
    Katzav, S., P. DeBaetselier, B. Tartakovsky, E. Gorelik, S. Segal and M. Feldman, Immunogenetic determinants controlling the metastatic properties of tumor cells. In: “Irnmunoregulation, 1981,” editor N. Fabris, in press.Google Scholar
  18. 18.
    Goldenberg, D.N., R.A. Pavia and M.C. Tsao, In vivo hybridization of human tumor and normal hamster cells. Nature 250:649 (1974).CrossRefGoogle Scholar
  19. 19.
    Wiener, F., E.M. Fenyo, G. Klein and H. Harris, Fusion of tumor cells with host cells. Nature New Biol. 238: 155 (1972).Google Scholar
  20. 20.
    DeBaetselier, P., E. Gorelik, Z. Eshhar, Y. Ron, S. Katzav, M. Feldman and S. Segal, Hybridization between plasmacytoma cells and B lymphocytes confers metastatic properties on a nonmetastatic tumor. J. Natl. Cancer Inst, in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • S. Katzav
    • 1
  • P. De Baetselier
    • 1
    • 2
  • B. Tartakovsky
    • 1
  • E. Gorelik
    • 1
    • 3
  • S. Segal
    • 1
  • M. Feldman
    • 1
  1. 1.Department of Cell BiologyThe Weizmann Institute of ScienceRehovotIsrael
  2. 2.Dienst Algemene BiologieVrije Universitait BrusselsBelgium
  3. 3.Division of SurgeryNational Cancer Institute, NIHBethesdaUSA

Personalised recommendations